An implant is a medical device that is surgically transplanted in the body to replace or support damaged body organs, enhance their functionalities, or detect flaws in functioning of organs. Medical devices can be placed either permanently or temporarily in the body, and can be removed when they are time-worned. These implantable devices are composed of bones, tissues, skin, ceramics, metals, and other natural materials.
The global implantable medical devices market was valued at $72,265 million in 2015, and is estimated to reach $116,300 million by 2022, registering a CAGR of 7.1% during the forecast period. The market is driven by factors such as rise in prevalence of chronic diseases and rapid increase in geriatric population. Moreover, increased awareness among individuals and rapid technological advancements in the medical implants sector fuel the market growth. However, high cost of implantation and dearth of skilled workforce hamper the market growth. Even then, this market is poised to grow at a CAGR of 10.7% from 2016 to 2022 (in terms of volume).
The global implantable medical devices market is segmented based on product type and geography. Based on product type, the market is categorized into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses, and other implants. The orthopedic implants segment contributed the highest revenue to the global market in 2015, owing to the large pool of patients undergoing orthopedic implants due to hyperactive lifestyle, unhealthy food habits, rise in geriatric population, and advancements in medical technologies. The other implants category was the fastest growing segment in 2015, due to increase in prevalence of neurological diseases, craniomaxillofacial deformities, and eye disorders; increase in the rate of cosmetic surgeries; and rise in geriatric population.
The market is segmented on the basis of four regions, namely North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share (nearly half) in the global implantable medical devices market in 2015 due to advancements in implantable medical devices and increase in prevalence of chronic diseases.
The Asia-Pacific region is expected to grow at the highest CAGR of 9.1% during the forecast period. The developing countries in the Asia-Pacific region, such as China and India, provide significant growth opportunities to market players, owing to the large population base and increase in awareness about the benefits of medical implants. Moreover, the report provides comprehensive analyses of the key players operating in the implantable medical devices market.
KEY BENEFITS
KEY MARKET SEGMENTS
The global implantable medical devices market is segmented based on product type and geography.
By Product
By Region
LIST OF KEY PLAYERS PROFILED IN THE REPORT
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report, but can be included on request)
Chapter: 1. INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2. EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
Chapter: 3. MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. Porters five forces analysis
3.3.1. Bargaining power of the suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of new entrants
3.3.4. High intensity of rivalry
3.3.5. Threat of substitutes
3.4. Top Player Positioning, 2015
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Growing elderly population and rise in prevalence of chronic diseases
3.5.1.2. Technological advancements in the field of implantable medical devices
3.5.1.3. Global rise in acceptance of implantable medical devices
3.5.1.4. Improvement of healthcare infrastructure in developing countries
3.5.1.5. Better insurance and reimbursement
3.5.1.6. Increasing government focus on funding R&D initiatives
3.5.1.7. Rising number of FDA approvals for performing clinical trials to benefit the market
3.5.2. Restraints
3.5.2.1. High cost of treatment associated with implantable medical devices
3.5.2.2. Stringent approval process as these are highly specialized devices
3.5.3. Opportunities
3.5.3.1. Huge market opportunities in the APAC region and developing countries
3.5.3.2. Increasing awareness amongst patients and increasing preference for a better quality of life
3.5.3.3. Increase in development of minimally invasive and non-surgical procedures
Chapter: 4. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Orthopedic implants
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Reconstructive joint replacements market size and forecast
4.2.5. Spinal implants market size and forecast
4.3. Cardiovascular implants
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. Intraocular lenses
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.5. Dental implants
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.6. Breast implants
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.7. Other implants
4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
Chapter: 5. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S. market size and forecast
5.2.5. Canada market size and forecast
5.2.6. Mexico market size and forecast
5.3. Europe
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany market size and forecast
5.3.5. France market size and forecast
5.3.6. UK market size and forecast
5.3.7. Rest of Europe market size and forecast
5.4. Asia-Pacific
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan market size and forecast
5.4.5. China market size and forecast
5.4.6. India market size and forecast
5.4.7. Rest of Asia-Pacific market size and forecast
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Latin America market size and forecast
5.5.5. Middle East market size and forecast
5.5.6. Africa market size and forecast
Chapter: 6. COMPANY PROFILES
6.1. Abbott Laboratories
6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves & developments
6.1.5. SWOT analysis
6.2. Biotronik SE & Co. KG
6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Key strategic moves & developments
6.2.4. SWOT analysis
6.3. Boston Scientific Corporation
6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves & developments
6.3.5. SWOT analysis
6.4. C. R. Bard, Inc.
6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves & developments
6.4.5. SWOT analysis
6.5. Cardinal Health, Inc.
6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves & developments
6.5.5. SWOT analysis
6.6. Conmed Corporation
6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. SWOT analysis
6.7. Globus Medical, Inc.
6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments
6.7.5. SWOT analysis
6.8. Integra Lifesciences Holdings Corporation
6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves & developments
6.8.5. SWOT analysis
6.9. Johnson & Johnson
6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves & developments
6.9.5. SWOT analysis
6.10. LivaNova PLC
6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves & developments
6.10.5. SWOT analysis
6.11. Medtronic plc
6.11.1. Company overview
6.11.2. Operating business segments
6.11.3. Business performance
6.11.4. Key strategic moves & developments
6.11.5. SWOT analysis
6.12. Nuvasive, Inc.
6.12.1. Company overview
6.12.2. Operating business segments
6.12.3. Business performance
6.12.4. Key strategic moves & developments
6.12.5. SWOT analysis
6.13. Smith & Nephew Plc
6.13.1. Company overview
6.13.2. Operating business segments
6.13.3. Business performance
6.13.4. Key strategic moves & developments
6.13.5. SWOT analysis
6.14. St. Jude Medical, Inc.
6.14.1. Company overview
6.14.2. Operating business segments
6.14.3. Business performance
6.14.4. Key strategic moves & developments
6.14.5. SWOT analysis
6.15. Institut Straumann AG.
6.15.1. Company overview
6.15.2. Business performance
6.15.3. Key strategic moves & developments
6.15.4. SWOT analysis
6.16. Stryker Corporation
6.16.1. Company overview
6.16.2. Operating business segments
6.16.3. Business performance
6.16.4. Key strategic moves & developments
6.16.5. SWOT analysis
6.17. Wright Medical Group N.V.
6.17.1. Company overview
6.17.2. Operating business segments
6.17.3. Business performance
6.17.4. Key strategic moves & developments
6.17.5. SWOT analysis
6.18. Zimmer Biomet Holdings, Inc.
6.18.1. Company overview
6.18.2. Operating business segments
6.18.3. Business performance
6.18.4. Key strategic moves & developments
6.18.5. SWOT analysis
List of Tables
TABLE 1. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 2. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT (THOUSAND UNITS), 2014-2022
TABLE 3. WORLD ORTHOPEDIC IMPLANTS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 4. WORLD ORTHOPEDIC IMPLANTS MARKET, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 5. WORLD ORTHOPEDIC IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 6. WORLD RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. WORLD SPINAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 8. WORLD CARDIOVASCULAR IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 9. WORLD INTRAOCULAR LENS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 10. WORLD DENTAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11. WORLD BREAST IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 12. WORLD OTHER IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 13. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 14. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 15. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 16. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 17. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 18. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 19. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 20. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 21. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 22. ABBOTT: COMPANY SNAPSHOT
TABLE 23. ABBOTT: OPERATING SEGMENTS
TABLE 24. BIOTRONIK- COMPANY SNAPSHOT
TABLE 25. BIOTRONIK: OPERATING SEGMENTS
TABLE 26. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 27. C. R. BARD- COMPANY SNAPSHOT
TABLE 28. CARDINAL HEALTH- COMPANY SNAPSHOT
TABLE 29. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 30. CONMED - COMPANY SNAPSHOT
TABLE 31. CONMED - PRODUCT CATEGORY
TABLE 32. GLOBUS MEDICAL- COMPANY SNAPSHOT
TABLE 33. GLOBUS MEDICAL: PRODUCT CATEGORIES
TABLE 34. INTEGRA LIFESCIENCES - COMPANY SNAPSHOT
TABLE 35. INTEGRA LIFESCIENCES: PRODUCT CATEGORY
TABLE 36. J &J: COMPANY SNAPSHOT
TABLE 37. LIVANOVA: - COMPANY SNAPSHOT
TABLE 38. LIVANOVA: OPERATING SEGMENTS
TABLE 39. MEDTRONIC - COMPANY SNAPSHOT
TABLE 40. MEDTRONIC: OPERATING SEGMENTS
TABLE 41. NUVASIVE- COMPANY SNAPSHOT
TABLE 42. NUVASIVE- OPERATING SEGMENTS
TABLE 43. SMITH & NEPHEW - COMPANY SNAPSHOT
TABLE 44. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 45. ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 46. INSTITUT STRAUMANN: COMPANY SNAPSHOT
TABLE 47. STRYKER - COMPANY SNAPSHOT
TABLE 48. ZIMMER BIOMET- COMPANY SNAPSHOT
List of Figures
FIGURE 1. IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS IN WORLD IMPLANTABLE MEDICAL DEVICES MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. PORTERS FIVE FORCES ANALYSIS
FIGURE 9. TOP PLAYER POSITIONING, 2015
FIGURE 10. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022
FIGURE 11. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT (THOUSAND UNITS), 2014-2022
FIGURE 12. WORLD ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT ($MILLION), 2014-2022
FIGURE 13. WORLD ORTHOPEDIC IMPLANTS MARKET, BY TYPE (THOUSAND UNITS), 2014-2022
FIGURE 14. WORLD ORTHOPEDIC IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 15. RECONSTRUCTIVE JOINT REPLACEMENTS MARKET ($MILLION), 2014-2022
FIGURE 16. WORLD RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 17. SPINAL IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 18. WORLD SPINAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 19. WORLD CARDIOVASCULAR IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 20. WORLD CARDIOVASCULAR IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 21. WORLD INTRAOCULAR LENS MARKET ($MILLION), 2014-2022
FIGURE 22. WORLD INTRAOCULAR LENS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 23. WORLD DENTAL IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 24. WORLD DENTAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 25. WORLD BREAST IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 26. WORLD BREAST IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 27. WORLD OTHER IMPLANTS MARKET ($MILLION), 2014-2022
FIGURE 28. WORLD OTHER IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 29. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 30. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 31. U.S. IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 32. CANADA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 33. MEXICO IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 34. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 35. GERMANY IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 36. FRANCE IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 37. U.K. IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 38. REST OF EUROPE IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 39. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 40. JAPAN IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 41. CHINA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 42. INDIA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 43. REST OF ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 44. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 45. LATIN AMERICA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 46. MIDDLE EAST IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 47. AFRICA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022
FIGURE 48. ABBOTT: REVENUE ($MILLION), 2013-2015
FIGURE 49. ABBOTT: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 50. ABBOTT: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 51. ABBOTT: SWOT ANALYSIS
FIGURE 52. BIOTRONIK- SWOT ANALYSIS
FIGURE 53. BOSTON SCIENTIFIC: REVENUE ($MILLION), 2013-2015
FIGURE 54. BOSTON SCIENTIFIC: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 55. BOSTON SCIENTIFIC: REVENUE, BY SUBSEGMENT (%), 2015
FIGURE 56. BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 57. BOSTON SCIENTIFIC: SWOT ANALYSIS
FIGURE 58. C. R. BARD: REVENUE ($MILLION), 2013-2015
FIGURE 59. C. R. BARD: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 60. C. R. BARD: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 61. C. R. BARD - SWOT ANALYSIS
FIGURE 62. CARDINAL HEALTH: REVENUE ($MILLION), 2013-2015
FIGURE 63. CARDINAL HEALTH: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 64. CARDINAL HEALTH: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 65. CARDINAL HEALTH: SWOT ANALYSIS
FIGURE 66. CONMED: REVENUE ($MILLION), 2013-2015
FIGURE 67. CONMED: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 68. CONMED: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 69. CONMED: SWOT ANALYSIS
FIGURE 70. GLOBUS MEDICAL: NET SALES ($MILLION), 2013-2015
FIGURE 71. GLOBUS MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY (%), 2015
FIGURE 72. GLOBUS MEDICAL: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 73. GLOBUS MEDICAL: SWOT ANALYSIS
FIGURE 74. INTEGRA LIFESCIENCES: REVENUE ($MILLION), 2013-2015
FIGURE 75. INTEGRA LIFESCIENCES: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 76. INTEGRA LIFESCIENCES: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 77. INTEGRA LIFESCIENCES - SWOT ANALYSIS
FIGURE 78. J&J: REVENUE ($MILLION), 2013-2015
FIGURE 79. J&J: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 80. J&J: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 81. J & J: SWOT ANALYSIS
FIGURE 82. LIVANOVA: NET SALES ($MILLION), 2013-2015
FIGURE 83. LIVANOVA: REVENUE, BY BUSINESS SEGMENT (%), 2015
FIGURE 84. LIVANOVA: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 85. LIVANOVA: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 86. LIVANOVA- SWOT ANALYSIS
FIGURE 87. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 88. MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)
FIGURE 89. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)
FIGURE 90. MEDTRONIC: SWOT ANALYSIS
FIGURE 91. NUVASIVE: REVENUE ($MILLION), 2013-2015
FIGURE 92. NUVASIVE: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 93. NUVASIVE: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 94. NUVASIVE: SWOT ANALYSIS
FIGURE 95. SMITH & NEPHEW: REVENUE ($MILLION), 2013-2015
FIGURE 96. SMITH & NEPHEW: REVENUE, BY PRODUCT TYPE (%), 2015
FIGURE 97. SMITH & NEPHEW: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 98. SMITH & NEPHEW: SWOT ANALYSIS
FIGURE 99. ST. JUDE MEDICAL: NET SALES ($MILLION), 2013-2015
FIGURE 100. ST. JUDE MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY (%), 2015
FIGURE 101. ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 102. ST. JUDE MEDICAL - SWOT ANALYSIS
FIGURE 103. STRAUMANN: REVENUE ($MILLION), 2013-2015
FIGURE 104. STRAUMANN: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 105. STRAUMANN: SWOT ANALYSIS
FIGURE 106. STRYKER: REVENUE ($MILLION), 2013-2015
FIGURE 107. STRYKER: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 108. STRYKER: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 109. STRYKER - SWOT ANALYSIS
FIGURE 110. WRIGHT- COMPANY SNAPSHOT
FIGURE 111. WRIGHT: REVENUE ($MILLION), 2013-2015
FIGURE 112. WRIGHT: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 113. WRIGHT: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 114. WRIGHT- SWOT ANALYSIS
FIGURE 115. ZIMMER BIOMET: REVENUE ($MILLION), 2013-2015
FIGURE 116. ZIMMER BIOMET: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015
FIGURE 117. ZIMMER BIOMET: REVENUE, BY GEOGRAPHY (%), 2015
FIGURE 118. ZIMMER BIOMET- SWOT ANALYSIS
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
